Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Shao

Showing results (1051-1060 of 1,142) with videos related to

Pageof 115
Sort By:
Journal of the National Cancer Institute|November 5, 2020
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast CancerDing Ma, Si-Yu Chen, Jin-Xiao Ren, et al.
Nature Communications|April 12, 2018
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patientsLi Chen, Liu Yang, Ling Yao, et al.
Protein & Cell|January 13, 2026
Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph NodesLinhui Zhai, Cui-Cui Liu, Lei Zhao, et al.
Clinical and Experimental Otorhinolaryngology|July 30, 2025
Prognostic utility of albumin-to-alkaline phosphatase ratio in head and neck cancer: A systematic review and metaanalysisYun-Ting Wang, Adarsh Kudva, Yen-Ting Lu, et al.
The Journal of Clinical Investigation|April 29, 2025
Kinesin-like protein KIFC2 stabilizes CDK4 to accelerate growth and confer resistance in HR+/HER2- breast cancerShao-Ying Yang, Ming-Liang Jin, Lisa Andriani, et al.
Cancer Cell|April 11, 2025
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancerDing Ma, Lei-Jie Dai, Xiang-Rong Wu, et al.
Cell Research|February 2, 2022
Comprehensive metabolomics expands precision medicine for triple-negative breast cancerYi Xiao, Ding Ma, Yun-Song Yang, et al.
Discover Oncology|June 21, 2024
BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancerZhi-Ming Shao, Li Cai, Shusen Wang, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
Prognostic Utility of the Modified Systemic Inflammation Score for Patients Undergoing Oral Cavity Cancer SurgeryKu-Hao Fang, Sheng-Wei Lo, Adarsh Kudva, et al.
NPJ Precision Oncology|September 7, 2024
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connectionChao You, Guan-Hua Su, Xu Zhang, et al.
Pageof 115

Showing results (1051-1060 of 1,142) with videos related to

Sort By:
Pageof 115
Journal of the National Cancer Institute|November 5, 2020
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast CancerDing Ma, Si-Yu Chen, Jin-Xiao Ren, et al.
Nature Communications|April 12, 2018
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patientsLi Chen, Liu Yang, Ling Yao, et al.
Protein & Cell|January 13, 2026
Multi-omics Analysis Reveals Comprehensive Aberrant Protein and Phosphorylation Characteristics in Breast Cancer and Paired Metastatic Lymph NodesLinhui Zhai, Cui-Cui Liu, Lei Zhao, et al.
Clinical and Experimental Otorhinolaryngology|July 30, 2025
Prognostic utility of albumin-to-alkaline phosphatase ratio in head and neck cancer: A systematic review and metaanalysisYun-Ting Wang, Adarsh Kudva, Yen-Ting Lu, et al.
The Journal of Clinical Investigation|April 29, 2025
Kinesin-like protein KIFC2 stabilizes CDK4 to accelerate growth and confer resistance in HR+/HER2- breast cancerShao-Ying Yang, Ming-Liang Jin, Lisa Andriani, et al.
Cancer Cell|April 11, 2025
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancerDing Ma, Lei-Jie Dai, Xiang-Rong Wu, et al.
Cell Research|February 2, 2022
Comprehensive metabolomics expands precision medicine for triple-negative breast cancerYi Xiao, Ding Ma, Yun-Song Yang, et al.
Discover Oncology|June 21, 2024
BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancerZhi-Ming Shao, Li Cai, Shusen Wang, et al.
Diagnostics (Basel, Switzerland)|January 8, 2025
Prognostic Utility of the Modified Systemic Inflammation Score for Patients Undergoing Oral Cavity Cancer SurgeryKu-Hao Fang, Sheng-Wei Lo, Adarsh Kudva, et al.
NPJ Precision Oncology|September 7, 2024
Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connectionChao You, Guan-Hua Su, Xu Zhang, et al.
Pageof 115